Cyhoeddiadau
Townson J, Cannings-John R, Francis N, Thayer D, Gregory JW. Presentation to primary care during the prodrome of Type 1 diabetes in childhood: a case-control study using record data linkage. Pediatr Diabetes. 2019 Feb 9. doi: 10.1111/pedi.12829. [Epub ahead of print]. PMID: 30737875.
Owens DR, Landgraf W, Frier BM, Zhang M, Home PD, Meneghini L, Bolli GB. Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0. Diabetes Obes Metab. 2019 Feb;21(2):321-329. doi: 10.1111/dom.13607. PMID: 30520217
Moser O, Eckstein ML, Mueller A, Birnbaumer P, Aberer F, Koehler G, Sourij C, Kojzar H, Holler P, Simi H, Pferschy P, Dietz P, Bracken RM, Hofmann P, Sourij H. Impact of physical exercise on sensor performance of the FreeStyle Libre intermittently viewed continuous glucose monitoring system in people with Type 1 diabetes: a randomized crossover trial. Diabet Med. 2019 Jan 24. doi: 10.1111/dme.13909. [Epub ahead of print]. PMID: 30677187
Parsons SN, Luzio SD, Harvey JN, Bain SC, Cheung WY, Watkins A, Owens DR. Effect of structured self-monitoring of blood glucose, with and without additional TeleCare support, on overall glycaemic control in non-insulin treated Type 2 diabetes: the SMBG Study, a 12-month randomized controlled trial. Diabet Med. 2019 Jan 17. doi: 10.1111/dme.13899. [Epub ahead of print]. PMID: 30653704. Read the lay summary here
Davies M, Bain S, Charpentier G, Flacke F, Goyeau H, Woloschak M, Hasslacher C, Vespasiani G, Edelman S. A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes. J Diabetes Sci Technol. 2019 Jan 15:1932296818821706. doi: 10.1177/1932296818821706. [Epub ahead of print]. PMID: 30646755
Dunseath GJ, Bright D, Luzio SD. Comparative Accuracy Evaluation of a Blood Glucose Meter With Novel Hematocrit Correction Technology, With Three Currently Used Commercially Available Blood Glucose Monitoring Systems. J Diabetes Sci Technol. 2019 Jan 9:1932296818821389. doi: 10.1177/1932296818821389. [Epub ahead of print]. PMID: 30623673
Verma S, Poulter NR, Bhatt DL, Bain SC, Buse JB, Leiter LA, Nauck MA, Pratley RE, Zinman B, Ørsted DD, Monk Fries T, Rasmussen S, Marso SP. Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke. Circulation. 2018 Dec 18;138(25):2884-2894. doi: 10.1161/CIRCULATIONAHA.118.034516. PMID: 30566004
Eckstein ML, Williams DM, O'Neil LK, Hayes J, Stephens JW, Bracken RM. Physical exercise and non-insulin glucose-lowering therapies in the management of Type 2 diabetes mellitus: a clinical review. Diabet Med. 2018 Dec 7. doi: 10.1111/dme.13865. [Epub ahead of print] Review. PMID: 30536728
Gilbert MP, Bain SC, Franek E, Jodar-Gimeno E, Nauck MA, Pratley R, Réa RR, Kerr Saraiva JF, Rasmussen S, Tornøe K, von Scholten BJ, Buse JB; and the LEADER Publication Committee on behalf of the LEADER Trial Investigators. Effect of liraglutide on cardiovascular outcomes in elderly patients: post hoc analysis of a randomized controlled trial. Ann Intern Med. 2018 Dec 4. doi: 10.7326/M18-1569. [Epub ahead of print] No abstract available. PMID: 30508430
McCarthy O, Bain SC, Deere R. Basal insulin reductions in anticipation of multiple exercise sessions in people with type 1 diabetes-a clinical perspective. Ann Transl Med. 2018 Dec;6(Suppl 2):S111. doi: 10.21037/atm.2018.11.63. No abstract available. PMID: 30740432.